Trial NCT00442403

View at ClinicalTrials.gov 
Org. Study IDs: FSP 97008500

Last trial update was posted on 2007-03-01

MeSH Interventions

Chloroquine Dehydroepiandrosterone

MeSH Conditions

Malaria

Other Conditions


Stopping Reasons

At the end of the year 2002, Cameroon switched from chloroquine to amodiaquine as first-line therapy for of uncomplicated malaria.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID